Skip to content

Intersect ENT, Inc.

Delisted

CIK 1271214fmd_0813H06BGBH02W08G65CM2YAXQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2012 to Mar 31, 2022, 38 periods

Latest annual · FY2021

Millions
Total revenues
107
Gross profit
77
Operating income
(141)
Net income
(160)
Free cash flow
(61)

Latest quarter · Q1 FY2022

Millions
Total revenues
22
Gross profit
14
Operating income
(27)
Net income
(29)
Free cash flow
(27)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
-0.5%
Revenue, 5 yearsFY2016 to FY2021
+6.3%
Net income, 5 yearsFY2016 to FY2021
n/m

Intersect ENT, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$106.7 million$80.6 million+32.5%10-K 2022-03-08 · proof
Gross profit$76.7 million$50.2 million+52.7%10-K 2022-03-08 · proof
Operating income-$141 million-$67.7 million10-K 2022-03-08 · proof
Net income-$159.6 million-$72.3 million10-K 2022-03-08 · proof
Cash from operating activities-$59.5 million-$35.7 million10-K 2022-03-08 · proof
Free cash flow-$61.5 million-$36.6 million10-K 2022-03-08 · proof
Total assets$146.9 million$227.4 million-35.4%10-K 2022-03-08 · proof
Total liabilities$215.9 million$160.4 million+34.6%10-K 2022-03-08 · proof
Cash and cash equivalents$38.4 million$13.5 million+184%10-K 2022-03-08 · proof
What was Intersect ENT, Inc.'s revenue in fiscal 2021?
Intersect ENT, Inc. reported revenue of $106.7 million for fiscal 2021 (the year ended Dec 31, 2021), against $80.6 million the year before (+32.5%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What was Intersect ENT, Inc.'s gross profit in fiscal 2021?
Intersect ENT, Inc. reported gross profit of $76.7 million for fiscal 2021 (the year ended Dec 31, 2021), against $50.2 million the year before (+52.7%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What was Intersect ENT, Inc.'s operating income in fiscal 2021?
Intersect ENT, Inc. reported operating income of -$141 million for fiscal 2021 (the year ended Dec 31, 2021), against -$67.7 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What was Intersect ENT, Inc.'s net income in fiscal 2021?
Intersect ENT, Inc. reported net income of -$159.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$72.3 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What was Intersect ENT, Inc.'s cash from operating activities in fiscal 2021?
Intersect ENT, Inc. reported cash from operating activities of -$59.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$35.7 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What was Intersect ENT, Inc.'s free cash flow in fiscal 2021?
Intersect ENT, Inc. reported free cash flow of -$61.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$36.6 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What are Intersect ENT, Inc.'s total assets?
As of Dec 31, 2021, Intersect ENT, Inc. reported total assets of $146.9 million, against $227.4 million a year earlier (-35.4%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What are Intersect ENT, Inc.'s total liabilities?
As of Dec 31, 2021, Intersect ENT, Inc. reported total liabilities of $215.9 million, against $160.4 million a year earlier (+34.6%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
What are Intersect ENT, Inc.'s cash and cash equivalents?
As of Dec 31, 2021, Intersect ENT, Inc. reported cash and cash equivalents of $38.4 million, against $13.5 million a year earlier (+184%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1271214&period_type=annual&limit=5"

Information only, not investment advice.